Apolipoprotein(a) gene polymorphisms (TTTTA)n and G/A-914 affect Lp(a) levels in ischemic heart disease patients from Serbia

Wien Klin Wochenschr. 2005 Jun;117(11-12):406-11. doi: 10.1007/s00508-005-0358-3.

Abstract

Objectives: Lipoprotein(a) (Lp(a)) concentration is determined primarily by the apolipoprotein(a) (apo(a)) gene. The pentanucleotide (TTTTA)n repeat and G/A-914 polymorphisms are in the 5' promoter region of the apo(a) gene. To elucidate whether these polymorphisms affect Lp(a) levels, a total of 211 Serbian adults were investigated.

Design: One hundred and eleven patients with ischemic heart disease and 100 healthy controls were genotyped and Lp(a) levels determined.

Results: Lp(a) concentrations differed according to the (TTTTA)n genotypes: among those having at least one allele 8, patients had significantly higher Lp(a) values than controls. A decreasing trend of Lp(a) values was associated with the -914A allele in controls but the opposite was true in patients. Patients with genotype TTTTA allele 8/AA-914 had significantly higher Lp(a) values than those without allele 8/AA (p < 0.05). The >8>8/GG genotype was not detected. Significant linkage disequilibrium between (TTTTA)n and G/A-914 polymorphism (p < 0.001) was found. In multivariate regression analysis, the G/A-914 polymorphism significantly (p < 0.05) affected Lp(a) levels in patients, after taking into account the (TTTTA)n polymorphism.

Conclusion: These results indicate that (TTTTA)n and G/A-914 polymorphisms affect Lp(a) levels in ischemic heart disease as a consequence of the linkage disequlibrium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5' Flanking Region / genetics
  • Adult
  • Aged
  • Alleles
  • Apolipoproteins / genetics
  • Apoprotein(a)
  • Epistasis, Genetic
  • Female
  • Genetic Predisposition to Disease / genetics
  • Genetics, Population
  • Genotype
  • Humans
  • Linkage Disequilibrium / genetics
  • Lipoprotein(a) / blood*
  • Lipoprotein(a) / genetics
  • Male
  • Microsatellite Repeats / genetics*
  • Middle Aged
  • Myocardial Ischemia / blood
  • Myocardial Ischemia / genetics*
  • Polymorphism, Genetic / genetics*
  • Promoter Regions, Genetic / genetics
  • Risk Factors
  • Yugoslavia

Substances

  • Apolipoproteins
  • Lipoprotein(a)
  • Apoprotein(a)